Status:
COMPLETED
Effect of Flexible Catheter Materials on Catheter Angle and Blood Vessel Irritation
Lead Sponsor:
Griffith University
Collaborating Sponsors:
Queensland University of Technology
University of Galway
Conditions:
Healthy
Intravenous Catheterization
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Peripheral intravenous catheters (PIVCs; commonly known as "cannulas") are very small tubes made out of rubber-like materials which are inserted into patients' arms using a needle to allow easy access...
Eligibility Criteria
Inclusion
- Adult aged 18-75 years.
- Not pregnant at time of recruitment and within 48 hrs of Day 1 procedures (self-reported)
- Normal haematology results as per reference range determined by the laboratory.
- Normal coagulation results as per reference range determined by the laboratory.
- Target cephalic veins readily cannulatable (i.e., \> 2 mm)
- Able and willing to provide verbal and written consent
- Must be an Australian citizen with current Medicare card
Exclusion
- History of pro coagulative state / condition (e.g., previous deep vein thrombosis)
- Currently on any anti-coagulant or platelet inhibitor medication. Use of NSAIDs and aspirin will be documented however are not exclusionary.
- Haemophilia or any current or history of bleeding disorder or tendency
- Presence or report of current blood borne disease/infection (e.g., hepatitis, HIV, leukemia, lymphoma)
- History of difficult vascular access
- Allergy or sensitivity to chlorhexidine gluconate, isopropyl alcohol, latex, or skin adhesives
- BMI \< 18.5 kg/m2 or ≥ 35 kg/m2
- Positive results for the urine drug screen at screening or check-in (including opiates, methadone, cocaine, amphetamines)
- History or presence of alcoholism (self-reported) or drug abuse within the past 2 years
- A current or previous medical, physical, mental / cognitive disorder or anatomical conditions that, in the opinion of the chief or sub-investigator, would place the patient at risk, would make them unable to perform study procedures or has the potential to confound interpretation of the study results. (e.g., musculo-skeletal injury, chronic back pain)
- Employed by Terumo, Becton Dickinson, Teleflex Medical, ICUMedical or BBraun (conflict of interest)
Key Trial Info
Start Date :
May 26 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 9 2025
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT06927141
Start Date
May 26 2025
End Date
October 9 2025
Last Update
November 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Griffith University
Southport, Queensland, Australia, 4215